990 resultados para 2,6,10,14,18-Pentamethyleicosan
Resumo:
Uma série de derivados quirais (e.e. > 99%) foram sintetizados a partir do meso- exo-(3R,5S)-3,5-dihidróximetilenotriciclo[5,2.1.02,6]decano com altos rendimentos, usando catálise enzimática (lipases) em reações de transesterificação. A resolução do respectivo diéster racêmico através da hidrólise catalisada com esterase (PLE) não forneceu o monoéster opticamente enriquecido; enquanto que a dessimetrização do anidrido usando indutores quirais (quinina e quinidina) resultou no monoéster opticamente enriquecido (e.e.≅ 60%). O respectivo amino-álcool protegido foi preparado. Alguns análogos inéditos de peptídeos restritos incorporados do triciclodecano foram sintetizados.
Resumo:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Resumo:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Resumo:
Neste trabalho, objetivou-se avaliar o efeito de métodos de superação de dormência e do ambiente de armazenamento sobre a qualidade fisiológica e fitopatológica das sementes de canafístula (Peltophorum dubium). As sementes foram submetidas aos seguintes tratamentos de superação de dormência: escarificação com lixa (200); imersão em água na temperatura ambiente, durante 24 e 72 h; imersão em ácido sulfúrico por 2, 6, 10, 15, 20 e 30 min; imersão em água quente (70, 80 e 90 C); e umedecimento do substrato com solução de KNO3 (0,2%). As sementes foram armazenadas na temperatura ambiente e a 10 C por 210 dias. Os efeitos dos tratamentos e do armazenamento foram avaliados por meio do teor de água, teste de germinação (cinco repetições de 30 sementes), de comprimento de plântulas e sanidade (400 sementes), com incubação por oito dias (22-25 C). Na análise estatística dos dados, utilizou-se o delineamento experimental inteiramente casualizado em esquema fatorial 2 x 14 (condições de armazenamento x tratamentos para a superação da dormência). As médias foram comparadas pelo teste de Tukey (P>0,5). Com relação às sementes não armazenadas, os melhores tratamentos para superar a dormência e promover a germinação foram escarificação com lixa ou ácido sulfúrico por 15 a 30 min; quanto às sementes armazenadas, houve a imersão em água quente (70 a 80 ºC). Os fungos detectados nas sementes foram Pestalotia sp., Alternaria sp., Rhizopus sp., Nigrospora sp., Curvularia sp., Fusarium sp., Rhizoctonia sp., Aspergillus sp., Cladosporium sp. e Fusarium semitectum.
Resumo:
The objective of this study was to evaluate the performance of broilers reared under different population densities in the cold and hot seasons of the year. Two identical experiments were conducted, one during the winter for 49 days, and the other during the summer where the chicks were slaughtered at 42 days of age. Commercial Hubbard broiler-type chicks were distributed in a randomized block design in a 4 × 2 factorial arrangement with population densities of 10, 14, 18, and 22 birds/m 2, by sex, and with four replications. Feed intake was reduced with a progressive decrease of available space for the chicks, and it resulted in a linear decrease in weight gain. However, there was a linear increase in the live weight of broilers in kilograms per area of floor space, proportional to the increase of population density, without effect on the viability. The progressive increment in the population density reduced the observed feed/gain ratio during the total winter rearing period for both sexes. There was no effect of population density on this characteristic during the hot season of the year. Population density did not affect the carcass yield of chicks during the summer. However, there was a linear increase on carcass yield with an increase in population density in the winter. The males, at the age slaughtered, had higher weights, feed intakes, and better feed/gain ratios, and lower abdominal fat and higher live weight production in kilograms per floor area than females. However, the viable index for the males was lower. From the results obtained, there was a linear increase in the liveweight of broilers in kilograms per floor area, making it possible to rear broilers under higher population densities, independent of the season of the year, as well as the occurrence of a decrease in feed intake and weight gain of the chicks with a decrease of available space.
Resumo:
Using the post-mitochondrial fraction of rat intestinal mucosa, we have investigated lycopene metabolism. The incubation media was composed of NAD+, KCI, and DTT with or without added lipoxygenase. The addition of lipoxygenase into the incubation significantly increased the production of lycopene metabolites. The enzymatic incubation products of 2H10 lycopene were separated using high-performance liquid chromatography and analyzed by UV/Vis spectrophotometer and atmospheric pressure chemical ionization-mass spectroscopy. We have identified two types of products: cleavage products and oxidation products. The cleavage products are likely: (1) 3-keto-apo-13-lycopenone (C18H24O2 or 6,10,14-trimethyl-12-one-3,5,7,9,13-pentadecapentaen-2-one) with lambdamax = 365 nm and m/z =272 and (2) 3,4-dehydro-5,6-dihydro-15-apo-lycopenal (C20H28O or 3,7,11,15-tetramethyl-2,4,6,8,12,14-hexadecahexaen-l-al) with lambdamax= 380 nm and m/z = 284. The oxidative metabolites are likely: (3) 2-ene-5,8-lycopenal-furanoxide (C37H50O) with lambdamax = 415 nm, 435 nm, and 470 nm, and m/z = 510; (4) lycopene-5, 6, 5', 6'-diepoxide (C40H56O2) with lambdamax = 415 nm, 440 nm, and 470 nm, and m/z =568; (5) lycopene-5,8-furanoxide isomer (I) (C40H56O2) with lambdamax = 410 nm, 440 nm, and 470 nm, and m/z = 552; (6) lycopene-5,8-epoxide isomer (II) (C40H56O) with lambdamax = 410, 440, 470 nm, and m/z = 552; and (7) 3-keto-lycopene-5',8'-furanoxide (C40H54O2) with lambdamax = 400 nm, 420 nm, and 450 nm, and m/z = 566. These results demonstrate that both central and excentric cleavage of lycopene occurs in the rat intestinal mucosa in the presence of soy lipoxygenase.
Resumo:
The first option for the treatment of UC is both: salicylates or corticoids. Recently, in late November of 2006, the Brazilian Ministry of Health has approved infliximab (Remicade c, Mantecorp, Brazil) to treat ulcerative colitis. We report the use of infliximab as a first option for the treatment of two patients with severe ulcerative colitis. Case report: Patient 1: AZF, 52 years-old, female, was first diagnosed with UC after history and clinical examination; colonoscopy showed pancolitis with positive biopsy (crypt microabscess). Her Mayo score was 10 (range: 0 to 12/asymptomatic to severe colitis). She received intra venous infusion of infliximab at a dose of 5mg/Kg of body weigh at week 0, 2, 6 and 14. Then, patient was given mesalazine 4.5 g/day for maintenance therapy. Clinical response was defined as a decreased from baseline in the total Mayo score of at least 3 points. At present, patient is asymptomatic with Mayo score of 3 one moth after the last dose of infliximab. Patient 2: MLA, 45 years-old, female was first diagnosed with bloody diarrhea; colonoscopy showed left colitis and the biopsy was positive for ulcerative colitis. Her Mayo score was 9. She was offered and accepted the step down treatment. She was given infliximab 5mg/Kg of body weight at week 0, 2, 6 and 14. After initial treatment with infliximab, she received mesalazine 4.2 g/day. At present, she is asymptomatic with Mayo score of 2 eighteen days after the last dose of infliximab. At our knowledge, this is the first Brazilian report of the use of infliximab as fist-line therapy in ulcerative colitis. Few days after the begging of the infusion, an impressive clinical and colonoscopy improvement was seen in these two patients. Recently, it has been reported the use of infliximab as first-line therapy in pediatric Crohn disease. Infliximab could be a good option in cases of moderate and severe UC to avoid the side effects of the use of high doses of corticoids in patients with moderate and severe UC. However, the question if step-down therapy in ulcerative colitis is better then conventional therapy with salicylates and corticoids needs to be answered by randomized trials.
Resumo:
Incluye Bibliografía
Resumo:
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
Resumo:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Resumo:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)